Your browser doesn't support javascript.
loading
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma.
Weiss, Glen J; Blaydorn, Lisa; Beck, Julia; Bornemann-Kolatzki, Kirsten; Urnovitz, Howard; Schütz, Ekkhard; Khemka, Vivek.
Afiliação
  • Weiss GJ; Western Regional Medical Center, Cancer Treatment Centers of America, Goodyear, AZ, USA. drglenweiss@outlook.com.
  • Blaydorn L; University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA. drglenweiss@outlook.com.
  • Beck J; Western Regional Medical Center, Cancer Treatment Centers of America, Goodyear, AZ, USA.
  • Bornemann-Kolatzki K; Chronix Biomedical, Göttingen, Germany.
  • Urnovitz H; Chronix Biomedical, Göttingen, Germany.
  • Schütz E; Chronix Biomedical, Göttingen, Germany.
  • Khemka V; Chronix Biomedical, Göttingen, Germany.
Invest New Drugs ; 36(1): 96-102, 2018 02.
Article em En | MEDLINE | ID: mdl-29119276
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Desoxicitidina / Albuminas / Anticorpos Monoclonais Humanizados / Antineoplásicos Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Desoxicitidina / Albuminas / Anticorpos Monoclonais Humanizados / Antineoplásicos Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article